Nanomedicine
- Multivalent protein binders/inhibitors and carrier-free drug delivery systems
for the treatment of diseases (e.g., cancer and sepsis), based on peptide-
nanoparticle conjugates and molecular self-assembly.
Related Publications:
- Biomacromolecules, 2023, 24(1), 141-149
- Journal of the American Chemical Society, 2020, 142(4), 1832-1837